Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-12-13

Clinical Trial Update: Psychosocial Screening for Neuroendocrine Tumor Patients

View source ↗

Summary

A clinical trial update describing psychosocial screening for patients with neuroendocrine tumors. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University | Conditions: Neuroendocrine Tumors | Status: UNKNOWN